Literature DB >> 11775000

A putative three-dimensional arrangement of the human serotonin transporter transmembrane helices: a tool to aid experimental studies.

A W Ravna1, O Edvardsen.   

Abstract

The human serotonin transporter is the molecular target for selective serotonin reuptake inhibitor drugs which are being used for treatment of depression. A three-dimensional model of the membrane spanning parts of the transporter was constructed. The transporter was assumed to consist of 12 transmembrane alpha-helices. The model was based on published experimental data of cocaine binding to mutant transporters, amino acid sequence analysis, and interactive molecular graphics. The model suggests that a high affinity cocaine binding site is situated in a region of the model where Asp98 acts like an anchor, while a putative low affinity site is situated in another region with Glu508 as the anchoring amino acid. A series of docking experiments with various reuptake inhibitors were conducted, using interactive molecular graphics techniques combined with energy calculations and analysis of the transporter-ligand complexes. Experiments involving molecular mapping of ligand binding areas may benefit from using the current model in experimental design. From the current model, several amino acids were proposed as prime candidates for mutagenesis and subsequent ligand binding studies. Also for evaluation of results from site directed mutagenesis experiments with SERT and similar transporters we assume the model will be helpful.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11775000     DOI: 10.1016/s1093-3263(01)00112-7

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  7 in total

Review 1.  Monoamine transporter structure, function, dynamics, and drug discovery: a computational perspective.

Authors:  Sankar Manepalli; Christopher K Surratt; Jeffry D Madura; Tammy L Nolan
Journal:  AAPS J       Date:  2012-08-24       Impact factor: 4.009

2.  Serotonin transporter modulation in blood lymphocytes from patients with major depression.

Authors:  Lucimey Lima; Mary Urbina
Journal:  Cell Mol Neurobiol       Date:  2002-12       Impact factor: 5.046

3.  Structure and localisation of drug binding sites on neurotransmitter transporters.

Authors:  Aina W Ravna; Ingebrigt Sylte; Svein G Dahl
Journal:  J Mol Model       Date:  2009-02-24       Impact factor: 1.810

4.  Structural determinants of species-selective substrate recognition in human and Drosophila serotonin transporters revealed through computational docking studies.

Authors:  Kristian W Kaufmann; Eric S Dawson; L Keith Henry; Julie R Field; Randy D Blakely; Jens Meiler
Journal:  Proteins       Date:  2009-02-15

5.  Helix XI contributes to the entrance of the serotonin transporter permeation pathway.

Authors:  Melissa I Torres-Altoro; Kellie J White; Gustavo J Rodríguez; David E Nichols; Eric L Barker
Journal:  Protein Sci       Date:  2008-07-15       Impact factor: 6.725

6.  Molecular model of the neural dopamine transporter.

Authors:  Aina Westrheim Ravna; Ingebrigt Sylte; Svein G Dahl
Journal:  J Comput Aided Mol Des       Date:  2003 May-Jun       Impact factor: 3.686

7.  Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter.

Authors:  Jacob Andersen; Lars Olsen; Kasper B Hansen; Olivier Taboureau; Flemming S Jørgensen; Anne Marie Jørgensen; Benny Bang-Andersen; Jan Egebjerg; Kristian Strømgaard; Anders S Kristensen
Journal:  J Biol Chem       Date:  2009-11-05       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.